Form 4: iRhythm Technologies CFO Daniel G. Wilson Reports Stock Transaction

Sentiment:

SEC Form 4


Daniel G. Wilson, CFO of iRhythm Technologies, reports the acquisition and disposal of common stock and restricted stock units.

Summary

  • On September 15, 2024, Daniel G. Wilson, the Chief Financial Officer of iRhythm Technologies, Inc., reported a transaction involving the company's common stock.
  • Wilson acquired 5,701 shares of common stock at $0.
  • Wilson disposed of 36,216 shares of common stock.
  • Following the reported transactions, Wilson beneficially owns 36,216 shares.
  • The report also mentions restricted stock units (RSUs), where each RSU represents a contingent right to receive one share of iRhythm's Common Stock.
  • 25% of the RSUs vest on September 1, 2025, and each one-year anniversary thereafter, contingent upon continued service.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing. The sentiment is neutral as it simply reports transactions without indicating a positive or negative outlook for the company.

Future Outlook

The vesting schedule of the RSUs indicates a continued service requirement for Wilson, aligning his interests with the company's long-term performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

  • Stock transactions by company executives are common and are reported via SEC Form 4 filings.
  • The vesting schedule of the RSUs is typical for executive compensation packages, designed to incentivize long-term performance and retention.
  • Comparable companies in the medical technology sector also utilize stock options and RSUs as part of their executive compensation plans.

Stakeholder Impact

  • The transaction provides transparency to shareholders regarding the CFO's stock ownership.
  • The vesting schedule of RSUs incentivizes the CFO to remain with the company, which benefits employees and other stakeholders.

Key Dates

DateDescription
09/15/2024Date of stock transaction (acquisition and disposal).
09/01/2025First vesting date for 25% of the restricted stock units.
12/27/2024Date of signature by attorney-in-fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.